(Q45280570)

English

Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes

scientific article

Statements

Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes (English)
Deborah Thomas
Miloslav Beran
Charles Koller
John Wright
Stephen A Bai
22 February 2005
2805-2812

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit